NCT06108791

Brief Summary

Surgical site infections (SSI) are the most common healthcare-associated infections and sources of morbidity and over-mortality. Factors that have been proven to reduce SSI include antimicrobial prophylaxis, maintenance of perioperative normothermia, avoidance of hyperglycemia, proper surgical techniques, and adequate pain relief postoperatively

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 31, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

April 3, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2026

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2026

Completed
Last Updated

June 29, 2026

Status Verified

June 1, 2026

Enrollment Period

1.2 years

First QC Date

October 25, 2023

Last Update Submit

June 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of SSI

    \- the incidence of SSI postoperatively according to the Centers for Disease Control (CDC) criteria up to 30 days

    30 DAYS

Secondary Outcomes (1)

  • Pulmonary complications

    14 days

Study Arms (2)

HIGH FIO2

ACTIVE COMPARATOR

will include 50 patients: each one will receive intraoperatively a high concentration of oxygen (80% oxygen + 20% air), following extubation, high-concentration oxygen supplementation will be maintained and given through non-rebreathing face mask with a reservoir at 10 L/min for 2 h.

Drug: FIO2=0.8

LOW FIO2

PLACEBO COMPARATOR

will include 50 patients: each one will receive intraoperatively standard concentration oxygen (33% oxygen + 66% air) followed by oxygen supplementation through the standard Venturi face mask of 30%

Drug: FIO2=0.33

Interventions

the concentration of intraoperative inspired fraction of oxygen is 80% oxygen + 20% air

HIGH FIO2

the concentration of intraoperative inspired fraction of oxygen is 33% oxygen + 66% air

LOW FIO2

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- BMI of \<35 kg/m2
  • scheduled for elective abdominal laparotomy/ laparoscopy under general anesthesia with an expected surgical time longer than 2 h.
  • ASA I and II

You may not qualify if:

  • \- Patients undergoing minor procedures, where the expected duration of surgery will be less than 1 hour.
  • emergency surgeries for bowel obstruction.
  • abdominal surgery for vascular or plastic indications.
  • patients with a recent history of fever,
  • patients with uncontrolled diabetes mellitus,
  • patient with known immunological dysfunction (on steroids, decompensated liver disease, HIV, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, 71515, Egypt

Location

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

October 25, 2023

First Posted

October 31, 2023

Study Start

April 3, 2025

Primary Completion

June 24, 2026

Study Completion

June 26, 2026

Last Updated

June 29, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations